Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Alterations in 5-HT1B Receptor Function by p11 in Depression-Like States
Per Svenningsson,1,2
Karima Chergui,2
Ilan Rachleff,1
Marc Flajolet,1
Xiaoqun Zhang,2
Malika El Yacoubi,3
Jean-Marie Vaugeois,3
George G. Nomikos,4
Paul Greengard1*
Abstract:
The pathophysiology of depression remains enigmatic, althoughabnormalities in serotonin signaling have been implicated. Wehave found that the serotonin 1B receptor [5-hydroxytryptamine(5-HT1B) receptor] interacts with p11. p11 increases localizationof 5-HT1B receptors at the cell surface. p11 is increased inrodent brains by antidepressants or electroconvulsive therapy,but decreased in an animal model of depression and in braintissue from depressed patients. Overexpression of p11 increases5-HT1B receptor function in cells and recapitulates certainbehaviors seen after antidepressant treatment in mice. p11 knockoutmice exhibit a depression-like phenotype and have reduced responsivenessto 5-HT1B receptor agonists and reduced behavioral reactionsto an antidepressant.
1 Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY 10021, USA. 2 Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden. 3 Unite de Neuropsychopharmacologie ExperimentaleCNRS FRE2735, European Institute for Peptide Research (IFRMP 23), Faculty of Medicine and Pharmacy, Rouen F76183 Cedex, France. 4 Neuroscience Discovery Research, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA.
* To whom correspondence should be addressed, E-mail: greengard{at}rockefeller.edu
The editors suggest the following Related Resources on Science sites:
In Science Magazine
PERSPECTIVES
Trevor Sharp (6 January 2006) Science311 (5757), 45.
[DOI: 10.1126/science.1122819] |Summary »|Full Text »|PDF »
A Noncanonical Postsynaptic Transport Route for a GPCR Belonging to the Serotonin Receptor Family.
T. Liebmann, M. Kruusmagi, N. Sourial-Bassillious, A. Bondar, P. Svenningsson, M. Flajolet, P. Greengard, L. Scott, H. Brismar, and A. Aperia (2012)
J. Neurosci.
32, 17998-18008
|Abstract »|Full Text »|PDF »
Next-Generation Treatments for Mental Disorders.
T. R. Insel (2012)
Science Translational Medicine
4, 155ps19
|Full Text »|PDF »
Cholinergic interneurons in the nucleus accumbens regulate depression-like behavior.
J. L. Warner-Schmidt, E. F. Schmidt, J. J. Marshall, A. J. Rubin, M. Arango-Lievano, M. G. Kaplitt, I. Ibanez-Tallon, N. Heintz, and P. Greengard (2012)
PNAS
109, 11360-11365
|Abstract »|Full Text »|PDF »
Genetic Deletion of Trace Amine 1 Receptors Reveals Their Role in Auto-Inhibiting the Actions of Ecstasy (MDMA).
B. Di Cara, R. Maggio, G. Aloisi, J.-M. Rivet, E. G. Lundius, T. Yoshitake, P. Svenningsson, M. Brocco, A. Gobert, L. De Groote, et al. (2011)
J. Neurosci.
31, 16928-16940
|Abstract »|Full Text »|PDF »
Regulation of fibrinolysis by S100A10 in vivo.
A. P. Surette, P. A. Madureira, K. D. Phipps, V. A. Miller, P. Svenningsson, and D. M. Waisman (2011)
Blood
118, 3172-3181
|Abstract »|Full Text »|PDF »
Cell-Type-Specific Modulation of Feedback Inhibition by Serotonin in the Hippocampus.
J. Winterer, A. V. Stempel, T. Dugladze, C. Foldy, N. Maziashvili, A. R. Zivkovic, J. Priller, I. Soltesz, T. Gloveli, and D. Schmitz (2011)
J. Neurosci.
31, 8464-8475
|Abstract »|Full Text »|PDF »
Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans.
J. L. Warner-Schmidt, K. E. Vanover, E. Y. Chen, J. J. Marshall, and P. Greengard (2011)
PNAS
108, 9262-9267
|Abstract »|Full Text »|PDF »
Counseling African Americans in Cardiac Rehabilitation: Implications for Comprehensive Lifestyle Modification.
N. T. Artinian and B. Franklin (2010)
American Journal of Lifestyle Medicine
4, 490-499
|Abstract »|PDF »
Kinetics of G-protein-coupled receptor endosomal trafficking pathways revealed by single quantum dots.
K. M. Fichter, M. Flajolet, P. Greengard, and T. Q. Vu (2010)
PNAS
107, 18658-18663
|Abstract »|Full Text »|PDF »
p11 and Gene Therapy for Severe Psychiatric Disorders: A Practical Goal?.
G. Chen, R. Twyman, and H. K. Manji (2010)
Science Translational Medicine
2, 54ps51
|Full Text »|PDF »
Reversal of Depressed Behaviors in Mice by p11 Gene Therapy in the Nucleus Accumbens.
B. Alexander, J. Warner-Schmidt, T. M. Eriksson, C. Tamminga, M. Arango-Lievano, S. Ghose, M. Vernov, M. Stavarache, S. Musatov, M. Flajolet, et al. (2010)
Science Translational Medicine
2, 54ra76
|Abstract »|Full Text »|PDF »
Serotonin shapes risky decision making in monkeys.
A. B. Long, C. M. Kuhn, and M. L. Platt (2009)
Soc Cogn Affect Neurosci
4, 346-356
|Abstract »|Full Text »|PDF »
Regulation of Serotonin 1B Receptor by Glycogen Synthase Kinase-3.
[N-methyl-3H3]AZ10419369 Binding to the 5-HT1B Receptor: In Vitro Characterization and in Vivo Receptor Occupancy.
D. L. Maier, C. Sobotka-Briner, M. Ding, M. E. Powell, Q. Jiang, G. Hill, J. R. Heys, C. S. Elmore, M. E. Pierson, and L. Mrzljak (2009)
J. Pharmacol. Exp. Ther.
330, 342-351
|Abstract »|Full Text »|PDF »
Reverse translational strategies for developing animal models of bipolar disorder.
O. Malkesman, D. R. Austin, G. Chen, and H. K. Manji (2009)
Dis. Model. Mech.
2, 238-245
|Abstract »|Full Text »|PDF »
Striatal Alterations of Secretogranin-1, Somatostatin, Prodynorphin, and Cholecystokinin Peptides in an Experimental Mouse Model of Parkinson Disease.
A. Nilsson, M. Falth, X. Zhang, K. Kultima, K. Skold, P. Svenningsson, and P. E. Andren (2009)
Mol. Cell. Proteomics
8, 1094-1104
|Abstract »|Full Text »|PDF »
Role of p11 in Cellular and Behavioral Effects of 5-HT4 Receptor Stimulation.
J. L. Warner-Schmidt, M. Flajolet, A. Maller, E. Y. Chen, H. Qi, P. Svenningsson, and P. Greengard (2009)
J. Neurosci.
29, 1937-1946
|Abstract »|Full Text »|PDF »
Targeting of the 5-HT1A Serotonin Receptor to Neuronal Dendrites Is Mediated by Yif1B.
D. Carrel, J. Masson, S. Al Awabdh, C. B. Capra, Z. Lenkei, M. Hamon, M. B. Emerit, and M. Darmon (2008)
J. Neurosci.
28, 8063-8073
|Abstract »|Full Text »|PDF »
Protein-Protein Interactions and Dopamine D2 Receptor Signaling: A Calcium Connection.
Endothelial Cell Annexin A2 Regulates Polyubiquitination and Degradation of Its Binding Partner S100A10/p11.
K.-L. He, A. B. Deora, H. Xiong, Q. Ling, B. B. Weksler, R. Niesvizky, and K. A. Hajjar (2008)
J. Biol. Chem.
283, 19192-19200
|Abstract »|Full Text »|PDF »
Evidence for a role of the 5-HT1B receptor and its adaptor protein, p11, in L-DOPA treatment of an animal model of Parkinsonism.
X. Zhang, P. E. Andren, P. Greengard, and P. Svenningsson (2008)
PNAS
105, 2163-2168
|Abstract »|Full Text »|PDF »
S100A16, a Novel Calcium-binding Protein of the EF-hand Superfamily.
E. Sturchler, J. A. Cox, I. Durussel, M. Weibel, and C. W. Heizmann (2006)
J. Biol. Chem.
281, 38905-38917
|Abstract »|Full Text »|PDF »
Deletion of Annexin 2 Light Chain p11 in Nociceptors Causes Deficits in Somatosensory Coding and Pain Behavior.
T. Foulkes, M. A. Nassar, T. Lane, E. A. Matthews, M. D. Baker, V. Gerke, K. Okuse, A. H. Dickenson, and J. N. Wood (2006)
J. Neurosci.
26, 10499-10507
|Abstract »|Full Text »|PDF »
Serotonin transport and serotonin transporter-mediated antidepressant recognition are controlled by 5-HT2B receptor signaling in serotonergic neuronal cells.
J.-M. Launay, B. Schneider, S. Loric, M. Da Prada, and O. Kellermann (2006)
FASEB J
20, 1843-1854
|Abstract »|Full Text »|PDF »
New Antidepressant Protein Helps Serotonin Work Better.
(2006)
Journal Watch Psychiatry
2006, 4
|Full Text »
NEUROSCIENCE: A New Molecule to Brighten the Mood.